New vaccine method is cheaper more effective, researchers say

Traditional vaccines can be ineffective and expensive. Now, an interdisciplinary team of Cornell researchers has devised a new way to make vaccines that promises to prevent diseases much more cheaply, the university announced Jan. 25. Read More »

Emergent BioSolutions signs $29.7 million contract to develop anthrax vaccine

ROCKVILLE, Md. Read More »

SFBR receives contract to test vaccines for Ebola, Marburg viruses


Emergent BioSolutions acquires monoclonal anthrax product candidate

ROCKVILLE, Md. Read More »

Genocea Biosciences awarded grant to develop of Chlamydia vaccine

Cambridge, Mass. Read More »

Several serious illnesses missing from U.S. vaccination plan, report says

While vaccines help prevent many diseases in the United States, the nation lacks immunization protection against several serious illnesses, according a new report from the Institute of Medicine. Read More »

NIAID testing candidate DNA vaccine for 2009 H1N1 influenza


NIAID trial of 2009 H1N1 influenza vaccine enrolling HIV-positive adults

HIV-infected adults are being recruited to participate in a clinical trial of 2009 H1N1 influenza vaccine, the National Institutes of Health announced Dec. 10. Read More »

N.Y. autopsies show 2009 H1N1 influenza virus damages entire airway

In fatal cases of 2009 H1N1 influenza, the virus can damage cells throughout the respiratory airway, much like the viruses that caused the 1918 and 1957 influenza pandemics. Read More »

Researcher studies why some vaccines may require a booster

ROCHESTER, N.Y. Read More »

Fighting tuberculosis should be priority, Fauci says

Dr. Anthony Fauci wrote this commentary, posted Nov. 17, for msnbc.com. He is director of the National Institute of Allergy and Infectious Diseases in Bethesda, Md. Read More »

FDA advisory panel votes 11-6 against new bug-based flu vaccine

BETHESDA, Md. Read More »

Scientists create NICE solution to pneumonia vaccine testing problems

Medical clinics could benefit from new software created at the National Institute of Standards and Technology, where a team of scientists has found a way to improve the efficiency of a pneumonia vaccine testing method. Read More »

Letter from the commissioner to nation's health care professionals on H1N1 vaccine

The following is an open letter dated Nov. 10 to health care professionals from Margaret A. Hamburg, commissioner of the Food and Drug Administration. Read More »

Study of key HIV antibodies could lead to new vaccine design

A study of how the most robust antibodies work to block HIV as it seeks entry into healthy cells has revealed a new direction for researchers hoping to design an effective vaccine, ScienceDaily reported Nov. 10. Read More »

NIAID announces research awards to fight emerging infectious diseases

The National Institute of Allergy and Infectious Diseases has awarded approximately $208 million to two programs that support research to better understand the human immune response to emerging and re-emerging infectious diseases. Read More »

Pregnant women have strong response to 1 dose of H1N1 vaccine

Healthy pregnant women mount a robust immune response following just one dose of 2009 H1N1 influenza vaccine, according to initial results from an ongoing clinical trial. Read More »

2nd dose of H1N1 vaccine elicits better response in youngest children

The National Institute of Allergy and Infectious Diseases announced interim trial results showing that children 9 years old and younger have improved immune response when given a second 15-microgram dose of 2009 H1N1 influenza vaccine. Read More »

Federal stimulus grant supports study of anti-nicotine vaccine

Efforts to develop a vaccine capable of preventing tobacco addiction got a $10 million shot in the arm in the form of an American Recovery and Reinvestment Act grant. Read More »

H1N1 vaccine 'remarkably safe,' NIH director says

CHICAGO Read More »